Human umbilical cord mesenchymal stem cell injection

DRUG3 trials

Sponsors

Shanghai Life Science & Technology, The First People's Hospital of Changzhou

Conditions

Diabetic Nephropathy Type 2Idiopathic Pulmonary FibrosisInterstitial Lung Disease

Phase 1

Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

CompletedNCT05468502

Shanghai Life Science & TechnologyIdiopathic Pulmonary Fibrosis

Start: 2022-10-10End: 2025-08-01Updated: 2025-12-26

Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease

Not yet recruitingNCT06534528

Shanghai Life Science & TechnologyInterstitial Lung Disease

Start: 2026-10-01End: 2027-10-01Target: 24Updated: 2026-05-11

Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy

Not yet recruitingNCT07769671

The First People's Hospital of ChangzhouDiabetic Nephropathy Type 2

Start: 2026-09-01End: 2029-08-31Target: 49Updated: 2026-08-18